Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 11 studies | 71% ± 20% | |
GABAergic neuron | 10 studies | 54% ± 19% | |
interneuron | 6 studies | 55% ± 22% | |
neuron | 5 studies | 35% ± 15% | |
microglial cell | 5 studies | 33% ± 20% | |
endothelial cell | 4 studies | 41% ± 22% | |
granule cell | 4 studies | 49% ± 28% | |
retinal ganglion cell | 4 studies | 70% ± 24% | |
GABAergic interneuron | 3 studies | 53% ± 4% | |
oligodendrocyte precursor cell | 3 studies | 21% ± 3% | |
GABAergic amacrine cell | 3 studies | 42% ± 18% | |
glycinergic amacrine cell | 3 studies | 37% ± 8% | |
astrocyte | 3 studies | 40% ± 30% | |
oligodendrocyte | 3 studies | 37% ± 26% | |
natural killer cell | 3 studies | 24% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 14 studies | 43% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 247.44 | 644 / 653 | 27% | 1.23 | 163 / 605 |
uterus | 93% | 917.25 | 158 / 170 | 21% | 1.15 | 96 / 459 |
brain | 77% | 164.05 | 2038 / 2642 | 25% | 0.92 | 178 / 705 |
stomach | 73% | 62.77 | 263 / 359 | 3% | 0.07 | 8 / 286 |
adrenal gland | 20% | 15.73 | 51 / 258 | 55% | 3.98 | 126 / 230 |
kidney | 64% | 27.38 | 57 / 89 | 6% | 0.21 | 55 / 901 |
skin | 14% | 5.74 | 252 / 1809 | 49% | 2.93 | 232 / 472 |
prostate | 57% | 73.21 | 139 / 245 | 4% | 0.07 | 18 / 502 |
bladder | 48% | 23.95 | 10 / 21 | 8% | 0.45 | 42 / 504 |
ovary | 21% | 14.98 | 38 / 180 | 24% | 0.68 | 104 / 430 |
pancreas | 18% | 6.85 | 60 / 328 | 15% | 0.40 | 26 / 178 |
eye | 0% | 0 | 0 / 0 | 29% | 0.85 | 23 / 80 |
intestine | 25% | 10.86 | 242 / 966 | 3% | 0.08 | 15 / 527 |
peripheral blood | 27% | 18.91 | 249 / 929 | 0% | 0 | 0 / 0 |
esophagus | 13% | 4.68 | 189 / 1445 | 11% | 0.44 | 21 / 183 |
lung | 7% | 2.76 | 40 / 578 | 14% | 0.45 | 162 / 1155 |
tonsil | 0% | 0 | 0 / 0 | 20% | 0.42 | 9 / 45 |
spleen | 16% | 5.26 | 38 / 241 | 0% | 0 | 0 / 0 |
breast | 7% | 2.97 | 34 / 459 | 4% | 0.09 | 45 / 1118 |
adipose | 9% | 4.50 | 108 / 1204 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 1% | 0.02 | 4 / 406 |
heart | 1% | 0.33 | 8 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.13 | 6 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.07 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051965 | Biological process | positive regulation of synapse assembly |
GO_0031012 | Cellular component | extracellular matrix |
GO_0016020 | Cellular component | membrane |
GO_0005615 | Cellular component | extracellular space |
Gene name | LINGO2 |
Protein name | Leucine rich repeat and Ig domain containing 2 Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 (Leucine-rich repeat neuronal protein 3) (Leucine-rich repeat neuronal protein 6C) LINGO2 protein |
Synonyms | UNQ9234/PRO31993 LERN3 LRRN6C |
Description | |
Accessions | Q7L985 A0A8V8TNG1 ENST00000698401.1 ENST00000698399.1 B7ZMN0 ENST00000698402.1 ENST00000698403.1 ENST00000698404.1 ENST00000698400.1 ENST00000379992.6 |